Related Experiment Videos
Abstract:
Computerized frequency analysis was used to quantitate the EEG effects of intrathecal metrizamide in 22 patients undergoing radiographic procedures. In comparison to baseline recordings, no changes were found immediately after the procedure, but a significant (p less than 0.001) shift to lower frequencies was seen at 16 to 26 hours. Individually significant changes were infrequent with lumbar myelograms or low-dose cisternograms and were most prominent in patients who had the combination of high metrizamide dose, cervical level, and a complex procedure with prolonged supine positioning.
Insights
Intrathecal metrizamide did not immediately affect EEG, but a significant shift to lower frequencies occurred 16-26 hours post-procedure, especially with higher doses and complex radiographic procedures.
Area of Science:
- Neuroscience
- Radiology
- Medical Imaging
Background:
- Metrizamide is a non-ionic contrast agent used in radiographic procedures.
- Understanding the central nervous system effects of intrathecal contrast agents is crucial for patient safety.
Purpose of the Study:
- To quantify the electroencephalogram (EEG) effects of intrathecal metrizamide.
- To identify factors influencing EEG changes following metrizamide administration.
Main Methods:
- Computerized frequency analysis of EEG recordings.
- 22 patients undergoing radiographic procedures with intrathecal metrizamide.
Main Results:
- No immediate EEG changes were observed post-procedure.
- A significant shift towards lower EEG frequencies (p < 0.001) occurred 16-26 hours after administration.
- EEG changes were more pronounced with higher metrizamide doses, cervical administration, and complex, prolonged procedures.
Conclusions:
- Intrathecal metrizamide can induce delayed, dose-dependent EEG alterations.
- Cervical administration and complex procedures exacerbate these delayed effects.